Kuros Biosciences - Exhibitor | |
Contact Information Maggie Brabbins - RSM Midwest US Follow Kuros on LinkedIn | ABOUT US: Kuros Biosciences aims to deliver decreased complications, advanced functional rehabilitation and to eliminate non-unions for spine surgeons and their patients. With over 40 peer-reviewed publications on surface-driven bone formation and more than 150 years of combined research experience, Kuros is well-established as leader in orthobiologics. Our focus is on revolutionizing this field by developing bone grafts that deliver both targeted and controlled bone healing. Kuros recently launched MagnetOs, a unique calcium phosphate bone graft with submicron surface topography, that harnesses the power of osteoimmunology to deliver uniform, solid and stable spinal fusions. Visit www.kurosbio.com for additional information on Kuros, its people, scientific data and product pipeline. Vist our website to find out more about Kuros: www.kurosbio.com Videos MagnetOs bone graft 3D Animation: The science behind the surface MagnetOs bone graft Testimonial: Two years clinical experience by Mr. Stewart Tucker, GOS, London PDFs Success is in The Surface – Summary of Key Facts Recent Publication - MagnetOs, Vitoss, and Novabone in a Multi-endpoint Study of Posterolateral Fusion: A True Fusion or Not? FDA-Cleared Data - Efficacy of a synthetic calcium phosphate with submicron surface topography as autograft extender in lapine posterolateral spinal fusion Clinical Evidence - Use of novel biphasic calcium phosphate with submicron surface topography in posterolateral fusion Becker’s Spine Review feature: This data-backed graft promotes bone formation, lowers costs in spinal fusion Kuros Biosciences announces Treatment of the First Patient in its Spinal Fusion Trial with Fibrin-PTH |
